Notably, the therapeutic efficacy of AMPs was evaluated in the clinical context not only for their direct antibacterial activity, but also the indirect immunomodulatory activity to promote the clearance of bacterial infection [3,12]. The gene discussed is ADSL; the disease is bacterial infectious disease.